BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2897481)

  • 1. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
    Sakai H; Oka H; Sakaguchi M
    Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
    Ishikawa M; Saito H; Sato J
    Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
    Sakai M
    Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Maintenance treatment of peptic ulcer and their problems].
    Iwasaki A; Matsuo Y
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):55-9. PubMed ID: 1673705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of peptic ulcers].
    Fukutomi H; Nakahara A
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):47-54. PubMed ID: 1673704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current aspects of course treatment and secondary prevention of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 9. Bedtime treatment of duodenal ulcer.
    Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical therapy of peptic ulcer: problems and prospects].
    Trabucchi E; Foschi D; Belloli P; Montorsi F; Marchetti V; Mariscotti C; Diamantini S
    Minerva Dietol Gastroenterol; 1989; 35(1):1-6. PubMed ID: 2566959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
    Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
    Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [H2 receptor antagonists and intragastric acidity].
    Dammann HG; Walter TA; Müller P; Simon B
    Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136
    [No Abstract]   [Full Text] [Related]  

  • 15. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modified H2 receptor blockers in ulcus therapy].
    Domschke S; Domschke W
    Dtsch Med Wochenschr; 1982 Dec; 107(48):1827-30. PubMed ID: 6128214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term therapy of gastroduodenal ulcer disease].
    Hahn L
    Z Arztl Fortbild (Jena); 1993; Suppl 1():1-3. PubMed ID: 7901947
    [No Abstract]   [Full Text] [Related]  

  • 19. [The status of H2-blocker therapy today].
    Rameis H
    Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term management of peptic ulcer. Indications and side effects of drug therapy compared with surgical procedure].
    Rösch W
    Fortschr Med; 1984 Jul; 102(25-26):688-91. PubMed ID: 6088375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.